The best part of my job as the Director of Global Policy and Scientific Affairs at DuPont Pioneer is getting to work with talented scientists across the globe. Through these relationships and ongoing biotech, trade and science advocacy efforts, I support the adoption of agricultural biotechnology in North America, Europe, Latin America, Asia and Africa. In previous roles I have worked on biotech safety/risk assessments and policy. In my free time, I enjoy cooking for family and friends.
From this Expert
Q: How much time does it take and how much does it cost to successfully develop a hybrid with one or more transgenic traits from conception to commercial release. Can you categorize the portion of costs that are incurred as a result of meeting...
Posted On: Wednesday, 9/11/2013 12:25 pm
Answered By: Wendelyn Jones, Director, Global Policy and Scientific Affairs, DuPont Pioneer, Thursday, 11/07/2013 3:10 pm
A: You are correct that it requires a tremendous investment of both time and resources to bring a new biotech crop to market. A survey completed in 2011 found the cost of discovery, development and authorization of a new plant biotechnology trait introduced between 2008 and 2012 was $136 million. On average, about 26 percent of those costs ($35.1 million) were incurred as part of the regulatory testing and registration process. The same study found that the average time from initiation of a... Continue Reading
Q: Why are over 65 countries around the world labeling food containing GMOs, but it's not supported by biotech companies in the U.S. (other than possibly being perceived as inferior to conventional food crops)? Also, why are some countries...
Posted On: Thursday, 8/01/2013 1:38 pm
Answered By: Wendelyn Jones, Director, Global Policy and Scientific Affairs, DuPont Pioneer, Wednesday, 11/27/2013 6:56 pm
A: Food packaging, labeling and marketing laws vary greatly by geography and even within geographies. In the United States, all food is labeled in accordance with Food and Drug Administration policy, which is the same for foods derived from biotechnology as it is for conventional foods. When a food product derived from biotechnology differs in composition, nutritional value or end use, that difference must be noted on the label, just as it is with other foods (e.g.,... Continue Reading
Q: How do you respond to the recent independent studies done by Dr. Judy Carmen of the Institute of Health and Environmental Research? The one I am referring to can be found here : http://www.iher.org.au/publications.php?pubID=16 They did a longterm (...
Posted On: Wednesday, 7/31/2013 4:56 pm
Answered By: Wendelyn Jones, Director, Global Policy and Scientific Affairs, DuPont Pioneer, Thursday, 12/19/2013 3:43 pm
A: As an employee of the agricultural biotechnology sector, I can attest that the industry takes any new studies related to the safety of GM crops very seriously. As such, I reviewed the paper by Carman et al. with interest at the time it was published and reread in order to best answer your question. The paper reports that pigs fed GMOs had inflamed stomachs based on visual evaluation of redness. However, the paper also shows that pigs fed non-GMO diets also had inflamed stomachs... Continue Reading
Q: How does your company give back to the communities and farmers who welcome the chance to grow crops for you?
Posted On: Tuesday, 7/30/2013 6:49 pm
Answered By: Wendelyn Jones, Director, Global Policy and Scientific Affairs, DuPont Pioneer, Tuesday, 8/27/2013 2:30 pm
A: At DuPont Pioneer, we are proud to give back to our communities. It's important to us to invest in the many neighborhoods around the globe where our customers and employees live and work. Among other commitments, we provide volunteer resources and financial contributions to help improve farmer safety, young-farmer opportunities, food quality and access, and education at all levels. For example, we contributed important sorghum research in Africa to increase the amount and stability of pro-... Continue Reading
Q: Given that 30 countries have banned GMO's, how can the U.S. biotech industry claim that GMO's are safe for human consumption and the environment without having conducted any long-term feeding studies? Along the same line, why doesn't...
Posted On: Monday, 7/29/2013 10:54 pm
Answered By: Wendelyn Jones, Director, Global Policy and Scientific Affairs, DuPont Pioneer, Friday, 11/15/2013 7:21 pm
A: GMO Answers has received several questions asking why GMOs have been banned in 30 countries or 60 countries. This is simply not true. Although GMOs may be grown on a small percentage of the hectares in some European countries, they routinely import GMOs for food and feed use. A previous response to a similar question discusses this issue in detail. We also commonly hear concern that there are no longer-term feeding studies. A review of several long-term feeding studies was... Continue Reading
No Studies were Found.